Clinical Trial Update: Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating paclitaxel micelle in combination with immunotherapy for biliary tract cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Paclitaxel micelle

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Biliary Tract Cancer (BTC) | Phase 2 | Status: RECRUITING